Maintenance for follicular lymphoma
Becky, our senior medical writer, looks at some of the questions raised about maintenance for follicular lymphoma at the post-ASH meeting.
Read the latest news and views from Lymphoma Action.
Use the drop down filter to find the most relevant news for you.
Becky, our senior medical writer, looks at some of the questions raised about maintenance for follicular lymphoma at the post-ASH meeting.
Becky, our senior medical writer, provides the latest instalment from the 2017 meeting of the American Society of Hematology.
Becky, our senior medical writer, provides the latest update from the 2017 meeting of the American Society of Hematology.
NICE recommends obinutuzimab (Gazyvaro) to be considered as part of first-line treatment for advanced follicular lymphoma.
Initial results from the phase 1/2 LYMRIT-37-01 clinical trial testing betalutin.
Becky, our senior medical writer, provides part one of an update from the 2017 meeting of the American Society of Hematology.
Initial results from the phase 2 SADAL trial, which has re-opened.
Results from the phase 2 CLARITY clinical trial have informed new treatment groups in the ongoing FLAIR trial.
Ex-pro footballer and Lymphoma Action supporter Tony Lormor shares his top tips for preparing for a challenge event.
Encouraging results from the first part of the ongoing OASIS clinical trial.